What is the Current Procedural Terminology (CPT) code for a follow‑up colonoscopy after a positive Cologuard (multitarget stool DNA test)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPT Coding for Follow-Up Colonoscopy After Positive Cologuard

For a follow-up colonoscopy after a positive Cologuard test, use CPT code 45378 (diagnostic colonoscopy) or the appropriate therapeutic colonoscopy code (45380-45385) if polyps are removed during the procedure.

Coding Framework

Diagnostic vs. Screening Classification

  • A colonoscopy performed after a positive Cologuard is coded as a diagnostic procedure, not a screening procedure, because it is investigating an abnormal finding 1
  • The positive Cologuard result changes the clinical indication from screening to diagnostic evaluation, which affects both CPT coding and insurance coverage 1

Primary CPT Codes to Use

  • CPT 45378: Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure) - use this when no polyps are found or removed 1
  • CPT 45380: Colonoscopy, flexible; with biopsy, single or multiple - use when biopsies are taken 1
  • CPT 45385: Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique - use when polyps are removed by snare 1
  • CPT 45384: Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps - use when appropriate 1

Important Coding Considerations

Medicare Coverage

  • For Medicare beneficiaries, the colonoscopy following a positive Cologuard should be billed as a diagnostic colonoscopy, not a screening colonoscopy 1
  • Medicare typically covers diagnostic colonoscopies at 80% after the Part B deductible is met, whereas screening colonoscopies are covered at 100% with no cost-sharing 1
  • The timing requirement is critical: colonoscopy should be performed within 6 months of the positive Cologuard to avoid increased risk of advanced-stage disease (adjusted OR 2.09,95% CI 1.43 to 3.06 for delays beyond 6 months) 2

Commercial Insurance

  • Most commercial payers follow similar logic, treating the follow-up colonoscopy as diagnostic rather than screening 1
  • Patient cost-sharing may apply for diagnostic procedures, unlike preventive screening colonoscopies which are typically covered at 100% under the Affordable Care Act 1

Common Coding Pitfalls to Avoid

Do Not Use Screening Codes

  • Avoid CPT G0121 (screening colonoscopy for high-risk individuals) or CPT G0105 (screening colonoscopy for average-risk individuals) - these are inappropriate when following up a positive Cologuard 1
  • Using screening codes when a diagnostic indication exists constitutes improper coding and may result in claim denials or compliance issues 1

Documentation Requirements

  • Medical records must clearly document that the colonoscopy is being performed due to a positive Cologuard result 1
  • Include the date of the positive Cologuard test and the specific indication for the procedure in the procedure note 1
  • If the colonoscopy is negative (no polyps or cancer found), document this clearly, as these patients should return to standard colonoscopy-based surveillance intervals rather than repeat Cologuard testing 1

Clinical Context for Coding

Expected Findings and Their Impact

  • Approximately 73% of patients with positive Cologuard will have neither cancer nor advanced adenomas on follow-up colonoscopy (false positive results) 3
  • When cancer is detected, it is most commonly found in the sigmoid colon, with 8 out of 10 patients having TNM stage ≥1 disease 3
  • Advanced adenomas are found in approximately 24% of patients with positive Cologuard who undergo colonoscopy 3

Timing and Urgency

  • Colonoscopy should be scheduled within 60 days according to Veterans Health Administration policy, though evidence suggests completion within 6 months is acceptable 2
  • Delays beyond 180 days show a trend toward increasing colorectal cancer risk, becoming statistically significant at >270 days (OR: 1.48, CI 1.05-2.08) 2
  • Each additional month of delay increases both CRC incidence and mortality by approximately 0.1 per 1,000 (a 1.4% monthly increase in mortality) 2

References

Guideline

Management of Patients with Positive Cologuard and Negative Colonoscopy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

How do I order Cologuard (Multitarget Stool DNA test) through Sonora Quest Laboratories?
What is the recommended interval for repeating a Cologuard (multitarget stool DNA test) screening in an average-risk individual with a negative result?
Is blood work required for Cologuard (stool‑based DNA test) colorectal cancer screening in average‑risk adults?
What are the contraindications for using Cologuard (multitarget stool DNA test) in patients?
What is the recommended follow-up for a 51-year-old man with a history of positive multitarget stool DNA (MT-sDNA) test for Colorectal Cancer (CRC) screening, followed by a normal colonoscopy?
For a 22‑year‑old woman with normal body‑mass index who is not breastfeeding, what is the earliest safe time to initiate combined oral contraceptive therapy postpartum?
In a male adult using supraphysiologic trenbolone 150 mg weekly and testosterone 400 mg weekly who presents with new‑onset dyspnea, what is the probability that a comprehensive cardiopulmonary work‑up is warranted and what are the five most likely differential diagnoses?
In a patient being treated with antiviral medication for herpes zoster who now has an open, oozing lesion, what additional management is indicated?
What is the maximum combined daily dose of mixed‑amphetamine salts (Adderall) when using both Adderall XR (extended‑release) and Adderall IR (immediate‑release) in adults and in children/adolescents?
In an adult female presenting with a cervical mass and a gallbladder mass, how should we evaluate whether these represent two primary tumors versus metastatic disease, and what are the recommended diagnostic steps and treatment options for each lesion?
What is the recommended minimum interval between a non‑emergency red blood cell transfusion and kidney transplantation, and how should HLA antibody screening be performed before the transplant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.